RecruitingNot ApplicableNCT05267041

Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)

Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection


Sponsor

Hospices Civils de Lyon

Enrollment

4,000 participants

Start Date

May 5, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial creates a comprehensive database of patients treated for thoracic (chest) cancers — including lung cancer and mesothelioma — at Lyon University Hospital to advance cancer research. **You may be eligible if...** - You are being treated for a thoracic cancer (such as non-small cell lung cancer, small cell lung cancer, or mesothelioma) at Lyon University Hospital - Your diagnosis was confirmed by pathology, cytology, or a multidisciplinary team decision **You may NOT be eligible if...** - You refuse to participate - For optional blood sampling: you weigh less than 30 kg or have no blood draw scheduled as part of your care Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interventions

BIOLOGICALBlood sample

One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer

OTHERQuestionnaire

to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.


Locations(1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05267041


Related Trials